With more then a four decade legacy of serving the information needs of marketing professionals within pharmaceutical companies and organizations serving them, Medical Marketing & Media provides numerous, integrated opportunities to reach out to this powerful and influential constituency. The attached link to MM&M's media kit highlights this in greater detail. Also, as the only 100% year one qualified publication serving the industry—as highlighted by our most recent BPA Statement—MM&M delivers access to the most current base and influential pool of marketing professionals working in the pharmaceutical industry today.
For additional information, please contact:
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.